Molecular Vision: Izuta, Mol Vis 2009; 15:2663-2672. Table 1

Table 1. Data for patients with proliferative diabetic retinopathy or macular hole.

Characteristic	Macular hole  (14 patients)	Proliferative diabetic retinopathy  (12 patients)
Age (years)	63.5±10.6	52.9±10.6
Number of women	13	7
Diabetes duration (years)	-	7.7±1.6
Clinical findings
Macular edema	-	4
Proliferative membrane	-	1
Traction membrane	-	1
Alone	-	2
Vitreous hemorrhage	-	7
Traction membrane	-	6
Proliferative membrane	-	8
Tractional retinal detachment	-	5
Alone	-	3
Pretreatments
Insulin	-	6
Hypoglycemic drug	-	6
Macular hole Stage 2	6	-
Macular hole Stage 3	8	-

The table indicates the baseline characteristics and the complications of proliferative diabetic retinopathy and macular hole patients. Complications of each patient are shown in “clinical findings,” and “pretreatments” indicates therapies until vitreous surgeries. In proliferative diabetic retinopathy, majority of complications were macular edema, vitreous hemorrhage, and proliferative membrane. 50% of the patients were pretreated with insulin, and the others were hypoglycemic drugs in proliferative diabetic patients. In macular hole patients, 6 patients were macular hole stage2, and 8 patients were macular hole stage3. “Age” and “Duration” data are mean±SD.